Early cervical carcinoma: How to manage high-risk patients after radical hysterectomy

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 85, Issue 2, 1999, Pages 137-139

  Samlal, Rahul A K ^a   Van Der Velden, Jacobus ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; EARLY CANCER; FEMALE; HIGH RISK PATIENT; HUMAN; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; SHORT SURVEY; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

EID: 0033181072     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(99)00015-9     Document Type: Editorial

References (17)

1. Samlal RAK, van der Velden J, van Eerden T, Schilthuis MS, Gonzalez Gonzalez D, Lammes FB. Recurrent cervical carcinoma after radical hysterectomy: An analysis of clinical aspects and prognosis. Int J Gynecol Cancer 1998;8:78-84.
2. Delgado G, Bundy B, Zaino R, Sevin B, Creasman WT, Major FM. Prospective surgical-pathological study of disease-free interval in patients with squamous cell carcinoma of the cervix: A gynecologic oncology group study. Gynecol Oncol 1990;38:352-7.
3. Kamura T, Tsukamoto N, Tsuruchi N. Multivariate analysis of the histopathologic prognostic factors of cervical cancer patients under-going radical hysterectomy. Cancer 1992;69:181-6.
4. Kinney WK, Alvarez RD, Reid GC. Value of adjuvant whole-pelvis irradiation after wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: A matched-control study. Gynecol Oncol 1989;34:258-62.
5. Lai C, Lin T, Soong Y, Phil M, Chen H. Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma. Gynecol Oncol 1989;35:193-8.
6. Samlal RAK, van der Velden JW, Ketting BW, Gonzalez Gonzalez D, ten Kate FJW, Lammes FB. Disease-free interval and recurrence with the Okabayashi variant of Wertheim's radical hysterectomy for stage IB and IIA cervical carcinoma. Int J Gynecol Cancer 1996;6:120-6.
7. Tattersall MHN, Ramirez C, Coppleson M. A randomised trial of adjuvant chemotherapy after radical hysterectomy in stage IB-IIA cervical cancer patients with pelvic lymph node metastases. Gynecol Oncol 1992;46:176-81.
8. Samlal RAK, van der Velden J, Schilthuis MS. Identification of high-risk groups among node-positive cervical carcinoma. Gynecol Oncol 1997;64:463-7.
9. Monk BJ, Cha DS, Walker JL. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage Ib and IIa cervical carcinoma. Gynecol Oncol 1994;54:4-9.
10. Samlal RAK, van der Velden J, ten Kate FJW, Schilthuis MS, Hart AAM, Lammes FB. Surgical pathological factors that predict recurrence in stage IB and IIA cervicalcarcinoma patients with negative pelvic lymph nodes. Cancer 1997;80:1234-40.
11. Sedlis A, Bundy BN, Rotman M. Treatment of selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: Pelvic radiation therapy (Rt) versus no further therapy (NFT) (A GOG study) (Abstract. Gynecol Oncol 1998;68:105-33.
12. Finan MA, DeCeSare S, Fiorca JV. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: Does the new staging system predict morbidity and survival? Gynecol Oncol 1996;62:139-47.
13. Landoni F, Maneo A, Colombo A. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997;350:535-40.
14. Eifel PJ, Burke TW, Morris M, Smith TL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol 1995;59:38-44.
15. Burghardt E, Batlzer J, Tulusan AH, Haas J. Results from surgical treatment of 1028 cervical cancers studied with volumetry. Cancer 1992;70:648-55.
16. Samlal RAK. The Wertheim Okabayashi Radical Hysterectomy for Early Stage Cervical Carcinoma. Academic Thesis, The Netherlands: University of Amsterdam, 1998.
17. Rettenmaier MA, Diane M, Casanova RN. Radical hysterectomy and tailored postoperative therapy in the management of bulky stage IB cervical cancer. Cancer 1989;65:2220-3.